New Technique Detects Novel Biomarkers for Kidney Diseases with Nephrotic Syndrome

A groundbreaking study, presented May 25, 2024 at the 61st European Associates (ERA) Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome.1 Using a hybrid technique, researchers identified anti-nephrin autoantibodies as a reliable biomarker for tracking disease progression, opening new avenues for personalized treatment approaches.

Login Or Register To Read Full Story